Skip to main content
. Author manuscript; available in PMC: 2023 Nov 15.
Published in final edited form as: Hypertension. 2022 Feb 15;79(4):775–784. doi: 10.1161/HYPERTENSIONAHA.121.18298

Table 3.

RHTN With Skeletal Muscle Biopsies for TEM

Age Sex Race BMI, kg/m2 BSA, m2 Diabetes Medications LVEF, % LVED Wall thickness, mm XO activity, μU/mg
RHTN
HTN01 35 F Black 40.9 2.27 No ARB, HB, CCB, diuretic N/A N/A 0.150
HTN04 48 M Black 29.7 2.26 No ACEi, BB, diuretic 65 4.9 0.369
HTN05 74 F White 28.3 1.85 No ARB, BB, CCB, diuretic 61.6 4.4 0.064
HTN08 70 F Black 33.0 1.97 Yes ACEi, BB, CCB, insulin 64.7 5.6 0.035
HTN10 55 F Black 32.2 1.72 Yes ARB, CCB, HBP, diuretic, insulin 65 4.3 NM
Normal
HTN20 35 F White 18.2 1.65 No None N/A N/A Undetectable
HTN21 50 M White 24 1.77 No None N/A N/A Undetectable

Medications:

ACEi indicates angiotensin II converting enzyme inhibitor;

ARB, angiotensin II receptor blocker;

BB, beta blocker;

CCB, calcium channel blocker;

HB, other high blood pressure medication;

LVED, left ventricular end-diastolic; LVEF, left ventricular ejection fraction; NM, not measured; and

XO, xanthine oxidase.